| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| Cost of Revenue | $0 | — | -100.0% |
| Gross Profit | $0 | — | -100.0% |
| R&D Expense | $542K | — | -27.1% |
| SG&A Expense | $889K | — | +0.0% |
| Operating Income | -$1.5M | — | +12.1% |
| Pre-tax Income | -$1.4M | — | +14.3% |
| Income Tax | $0 | — | — |
| Net Income | -$1.4M | — | +14.2% |
| EPS (Diluted) | -$0.38 | — | -145.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $125K | — | — |
| Current Assets | $6.1M | -18.1% | -22.8% |
| Total Assets | $6.4M | -17.5% | -22.8% |
| Current Liabilities | $308K | +8.0% | +7.4% |
| Total Liabilities | $308K | +8.0% | +7.4% |
| Stockholders' Equity | $6.1M | -18.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | +16.9% |
| Investing Cash Flow | -$175K | — | — |
| Financing Cash Flow | $13K | — | -99.6% |
| -24.2% |